UPC Universe Pharmaceuticals INC

Fundamentals / CIK 0001809616 / USD

Universe Pharmaceuticals INC reported $17.86B in revenue and a net loss of $3.67B for the fiscal year ended September 30, 2025 (down 22.4% year over year), with a 35.3% gross margin and a -16.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open UPC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$32.77B$16.38B$0-$10.91BFY 2019 Revenue: $33.23MFY 2019 Net Income: $7.55M2019FY 2020 Revenue: $30.70MFY 2020 Net Income: $7.56M2020FY 2021 Revenue: $47.98MFY 2021 Net Income: $11.32M2021FY 2022 Revenue: $40.14MFY 2022 Net Income: -$7.91M2022FY 2023 Revenue: $32.31BFY 2023 Net Income: -$6.58B2023FY 2024 Revenue: $23.02BFY 2024 Net Income: -$8.73B2024FY 2025 Revenue: $17.86BFY 2025 Net Income: -$3.67B2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Revenue $17.86B $23.02B $32.31B $40.14M $47.98M $30.70M $33.23M
Cost of Revenue $11.56B $16.95B $21.99B $18.25M $22.66M $16.61M $19.82M
Gross Profit $6.30B $6.07B $10.32B $21.89M $25.33M $14.09M $13.41M
Research & Development $671.8M $3.03B $4.86B $7.64M $5.47M $583K $618K
Selling, General & Admin $8.55B $11.06B $9.42B $21.27M $6.27M $3.26M $3.04M
Total Operating Expenses $9.22B $14.09B $14.28B $28.91M $11.74M $3.84M $3.65M
Operating Income -$2.92B -$8.02B -$3.97B -$7.02M $13.59M $10.25M $9.75M
EBITDA -$2.40B -$7.53B -$3.46B -$6.49M $14.04M $10.66M $10.17M
Interest Expense $289.4M $304.5M $190.2M $162K $102K $124K $129K
Income Before Tax -$3.67B -$8.12B -$4.33B -$7.09M $13.68M $10.10M $9.65M
Income Tax Expense -- $606.7M $2.25B $815K $2.36M $2.54M $2.10M
Net Income -$3.67B -$8.73B -$6.58B -$7.91M $11.32M $7.56M $7.55M
Basic EPS -$8.06 -$626.96 -$1,089.21 -$1,309.11 $2,105.88 $1,658.49 $1,658.49
Diluted EPS -$8.06 -$626.96 -$1,089.21 -$1,309.11 $2,105.88 $1,658.49 $1,658.49
Basic Shares Outstanding 455.9K 13.9K 6.0K 6.0K 5.4K 4.5K 4.5K
Diluted Shares Outstanding 455.9K 13.9K 6.0K 6.0K 5.4K 4.5K 4.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for UPC.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $33.59B $29.50B $5.29M $5.71M $8.08M $10.06M
Short-Term Investments -- -- $13.22M $13.15M $13.73M --
Cash & Short-Term Investments $33.59B $29.50B $18.50M $18.86M $21.80M $10.06M
Accounts Receivable, Net $13.01B $12.91B $11.01M $15.18M $15.57M $10.87M
Inventory $2.19B $1.74B $3.34M $2.21M $2.46M $1.91M
Total Current Assets $53.60B $51.64B $25.27M $41.51M $50.48M $23.28M
Property, Plant & Equipment, Net $3.58B $3.57B $3.70M $4.25M $4.68M $4.43M
Intangible Assets $296.8M $262.9M $149K $157K $149K $175K
Total Non-Current Assets $15.70B $16.32B $16.45M $18.03M $19.66M $5.52M
Total Assets $69.30B $67.95B $41.72M $59.54M $70.14M $28.80M
Accounts Payable $1.67B $4.91B $4.59M $3.08M $5.31M $2.69M
Short-Term Debt $9.26B $5.86B $5.48M $3.94M $4.33M $2.65M
Deferred Revenue (Current) $40.71M -- -- -- -- --
Total Current Liabilities $13.17B $20.31B $13.75M $13.10M $11.21M $8.00M
Total Non-Current Liabilities $0 $2.14B $0 -- $11.94M $0
Total Liabilities $13.17B $22.45B $13.75M -- $23.15M $8.00M
Total Debt (incl. Leases) $9.26B $5.86B $5.48M $3.94M $4.33M $2.65M
Common Stock $6.34B $482.4M $68K $68K $68K $50K
Retained Earnings -$13.84B -$10.17B -$1.44M $16.32M $25.06M $13.74M
Accumulated Other Comp. Income -$1.81B -$1.11B -$2.37M -$1.67M $2.09M $895K
Total Stockholders' Equity $56.13B $45.50B $27.97B $35.33B $46.99M $20.80M
Total Equity $56.13B $45.50B $27.97B $35.33B $46.99M $20.80M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30 2020-09-30
Cash & Cash Equivalents $33.59B $29.50B $5.29M $5.71M $8.08M $10.06M
Short-Term Investments -- -- $13.22M $13.15M $13.73M --
Cash & Short-Term Investments $33.59B $29.50B $18.50M $18.86M $21.80M $10.06M
Accounts Receivable, Net $13.01B $12.91B $11.01M $15.18M $15.57M $10.87M
Inventory $2.19B $1.74B $3.34M $2.21M $2.46M $1.91M
Total Current Assets $53.60B $51.64B $25.27M $41.51M $50.48M $23.28M
Property, Plant & Equipment, Net $3.58B $3.57B $3.70M $4.25M $4.68M $4.43M
Intangible Assets $296.8M $262.9M $149K $157K $149K $175K
Total Non-Current Assets $15.70B $16.32B $16.45M $18.03M $19.66M $5.52M
Total Assets $69.30B $67.95B $41.72M $59.54M $70.14M $28.80M
Accounts Payable $1.67B $4.91B $4.59M $3.08M $5.31M $2.69M
Short-Term Debt $9.26B $5.86B $5.48M $3.94M $4.33M $2.65M
Deferred Revenue (Current) $40.71M -- -- -- -- --
Total Current Liabilities $13.17B $20.31B $13.75M $13.10M $11.21M $8.00M
Total Non-Current Liabilities $0 $2.14B $0 -- $11.94M $0
Total Liabilities $13.17B $22.45B $13.75M -- $23.15M $8.00M
Total Debt (incl. Leases) $9.26B $5.86B $5.48M $3.94M $4.33M $2.65M
Common Stock $6.34B $482.4M $68K $68K $68K $50K
Retained Earnings -$13.84B -$10.17B -$1.44M $16.32M $25.06M $13.74M
Accumulated Other Comp. Income -$1.81B -$1.11B -$2.37M -$1.67M $2.09M $895K
Total Stockholders' Equity $56.13B $45.50B $27.97B $35.33B $46.99M $20.80M
Total Equity $56.13B $45.50B $27.97B $35.33B $46.99M $20.80M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$3.67B -$8.73B -$6.58B -$8.74M $11.32M $7.56M $7.55M
Depreciation & Amortization $517.4M $485.7M $508.8M $534K $447K $410K $418K
Change in Receivables -$169.0M -$1.55B $4.72B -$1.53M -$3.87M -$4.11M $665K
Change in Inventory -$474.6M $1.64B -$1.18B $17K -$452K $889K $5.59M
Change in Payables -$3.13B $143.7M $1.64B -$1.92M $2.46M $639K -$924K
Operating Cash Flow -$5.05B -$9.51B $1.12B -$1.30M -$2.06M $6.12M $13.20M
Capital Expenditure -$266.8M -$208.3M -$44.17M -$94K -$445K -$52K -$86K
Free Cash Flow -$5.32B -$9.72B $1.07B -$1.40M -$2.50M $6.06M $13.12M
Investing Cash Flow -$341.8M -$361.3M -$44.17M -$3.91M -$27.06M -$52K -$86K
Common Stock Issued $15.00B $25.00B -- -- -- -- --
Dividends Paid -- -- -- -- -- -- -$16.00M
Financing Cash Flow $9.73B $33.95B -$1.39B $3.32M $26.58M $470K -$16.00M
Net Change in Cash $4.09B $24.21B -$426.2M -$2.37M -$1.98M $6.88M -$3.01M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for UPC.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Gross Margin 35.3% 26.4% 31.9% 54.5% 52.8% 45.9% 40.3%
Operating Margin -16.3% -34.8% -12.3% -17.5% 28.3% 33.4% 29.4%
Net Profit Margin -20.6% -37.9% -20.4% -19.7% 23.6% 24.6% 22.7%
Return on Equity (ROE) -6.5% -19.2% -23.5% 0.0% 24.1% 36.3% --
Return on Assets (ROA) -5.3% -12.8% -15772.6% -13.3% 16.1% 26.2% --
Current Ratio 4.07x 2.54x 1.84x 3.17x 4.50x 2.91x --
Quick Ratio 3.90x 2.46x 1.59x 3.00x 4.28x 2.67x --
Debt to Equity 0.16x 0.13x 0.00x 0.00x 0.09x 0.13x --
Revenue Growth (YoY) -22.4% -28.7% +80383.8% -16.3% +56.3% -7.6% --
Gross Profit Growth (YoY) +3.8% -41.1% +47019.7% -13.6% +79.7% +5.1% --
Operating Income Growth (YoY) -- -- -- -151.7% +32.6% +5.1% --
Net Income Growth (YoY) -- -- -- -169.9% +49.8% +0.1% --
EPS Growth (YoY) -- -- -- -162.2% +27.0% 0.0% --
Operating Cash Flow Growth (YoY) -- -951.3% -- -- -133.6% -53.7% --
Free Cash Flow Growth (YoY) -- -1005.7% -- -- -141.2% -53.8% --
5Y Revenue / Share Growth +478.5% +22468.9% -- -- -- -- --
5Y Net Income / Share Growth -583.2% -37743.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for UPC.
Source: SEC EDGAR CompanyFacts (CIK 0001809616) · from September 30, 2019 Data through September 30, 2025 · synced Nov 21, 2026, 05:13 UTC · Open in terminal